Literature DB >> 12552296

Prevalence and correlates of irritable bowel symptoms in a New Zealand birth cohort.

Gil Barbezat1, Richie Poulton, Barry Milne, Stuart Howell, J Paul Fawcett, Nicholas Talley.   

Abstract

AIM: To determine the prevalence and correlates of bowel symptoms and the irritable bowel syndrome (IBS) in a birth cohort of young New Zealanders.
METHODS: Participants in the Dunedin Multidisciplinary Health and Development Study at age 26 completed a validated Bowel Disease Questionnaire expressing their experience of clearly defined symptoms over the previous 12 months.
RESULTS: 980 participants (499 male, 481 female, comprising 96% of the birth cohort) completed the questionnaire. Sixty four per cent had at least one of the measured symptoms; abdominal pain was reported in 46.5%, chronic constipation in 9.1%, and chronic diarrhoea in 17.1%. A diagnosis of IBS could be made by using two or more of Manning's diagnostic criteria in 18.8%, three or more criteria in 10.3%, and more than three in 3.3%. Symptoms were more than twice as frequent and severe in females than males.
CONCLUSIONS: Bowel-related abdominal symptoms, including those required for a diagnosis of IBS, are very common in 26-year-old New Zealanders; the prevalence of these symptoms is very similar to that recorded previously in Europe and the USA.

Entities:  

Mesh:

Year:  2002        PMID: 12552296

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  11 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?

Authors:  Shunji Ishihara; Monowar Aziz; Naoki Oshima; Yoshiyuki Mishima; Hiroshi Imaoka; Ichiro Moriyama; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2009-01-06

3.  Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT).

Authors:  Phoebe Heenan; Rob H Creemers; Shriya Sharma; Jacqueline Keenan; Simone Bayer; Wayne Young; Janine Cooney; Kelly Armstrong; Karl Fraser; Paula M Skidmore; Nicholas J Talley; Nicole Roy; Richard B Gearry
Journal:  Inflamm Intest Dis       Date:  2020-07-08

4.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 5.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

6.  Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life.

Authors:  Jian-Min Si; Liang-Jing Wang; Shu-Jie Chen; Lei-Min Sun; Ning Dai
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

7.  Familial aggregation of irritable bowel syndrome: a prospective study.

Authors:  J S Kalantar; G R Locke; A R Zinsmeister; C M Beighley; N J Talley
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

8.  Epidemiology and Risk Factors of Functional Constipation in Pregnant Women.

Authors:  Wenjun Shi; Xiaohang Xu; Yi Zhang; Sa Guo; Jing Wang; Jianjun Wang
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 9.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790

Review 10.  Guidelines on the irritable bowel syndrome: mechanisms and practical management.

Authors:  R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell
Journal:  Gut       Date:  2007-05-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.